Abstract:Objective To discuss the androgen receptor (AR expresion and its association with clinicopathological features and prognosis in early stage triple-negative breast cancer patients (TNBC).Methods The present study retrospectively analyzed the clinic data of 1 018 patients with early-stage invasive breast cancer treated at the Breast Disease Center at Peking University First Hospital between January 2014 and December 2016,including 1 011 females and 7 males;the age range was 21 to 92 years,and the median age was 57 years.Patients with TNBC were enrolled,and divided into AR positive group and AR negative group according to the expression of AR.The clinicopathological features were analysed,including menopause status,pathological type,T staging,lymph node involvement,anatomic staging,prognostic staging,Ki-67 index,histological grade,vascular tumor thrombus and neuroinvation,and the correlation between the expression of AR and clinicopathological features,curative effect of neoadjuvant chemotherapy and prognosis were calculated.The Student's t test was used to compare continuous data,the Pearsonx2 test or Fisher exact test was used to compare categorical variables,and the Mann-Whitney U test was used for quantitative data.The Kaplan-Meier method was used to analyze survival status,and comparisons between groups were calculated by the log-rank test.Results This study included 148 TNBC,accounting for 14.5％ of all patients,in which all patients were females,and the median age was 55 years,ranging from 27 years to 75 years.The number of AR-positive TNBC was 59,accounted for 39.9％ of all TNBC patients,and the numbers of AR-negative were 89,accounted for 60.1％.Ki-67 index,histological grade and prognostic stage were significantly different in AR-positive and AR-negative TNBC (P ＜ 0.05).There was no statistically significant difference between AR-positive TNBC and AR-negative TNBC in OS (98.3％ vs 95.4％,P =0.830) or in DFS (91.4％ vs 91.0％,P =0.812).Among TNBC who received neoadjuvant chemotherapy,AR-positive patients showed a lower pCR rate than AR-negative patients (x2 =4.381,P =0.046).Conclusions AR expression is associated with lower respond to neoadjuvant chemotherapy in TNBC.However,the association between AR expression and prognosis in TNBCs was still not clear.

Expression of P53, CK5/6 and AR in Three Negative Nreast Cancer of El-derly Women

Expression of Androgen Receptor in Breast Cancer and Its Prognostic Significance

A Study on Pertinence of Pathologic and Biology Features in HER-2, ER and PR Negative Breast Cancer

Expression and Significance of Ki-67 and p53 in Triple Negative Breast Cancer

P53 and Ki-67 As Prognostic Markers in Triple-Negative Breast Cancer Patients

Correlation of p53 expression with triple negative breast cancer and its prognosis:a meta analysis

Clinical Pathological Analysis of Elderly Female Patients with Triple-Negative Breast Cancer

Correlation of Expressions of ER, PR and C-Erbb-2 to Clinicopathologic Factors in Breast Cancer

Expression of NM-23,PCNA,p53 and S-100 in Colorectal Carcinoma in the Elderly and Their Relationship

The Expression of Estrogen Receptor Α, Β in Different Breast Tissues and Its Relation with Breast Cancer

Expressions of estrogen receptor and progesterone receptor in elderly breast cancer patients and its relationship with clinical pathology

Androgen receptor expression and association with clinicopathological features and prognosis in early stage triple-negative breast cancer

[Relationship Between the Protein Expression of P53, C-Erbb-2, Vascular Endothelial Growth Factor and CD44 and the Survival Rates of Stage II( Colorectal Cancer Patients Without Radiochemotherapy after Radical Resection].

[Expression of CK5/6 and CK17 and Its Correlation with Prognosis of Triple-Negative Breast Cancer Patients].

Expression of Androgen Receptor and Epidermal Growth Factor Receptor in Invasive Breast Cancer: A Retrospective Study of 1,438 Patients from China.

Clinicopathological importance of Bcl‐2 and p53 in postmenopausal triple‐negative breast carcinoma and association with age

Evaluation of Nm23,c-Erbb-2 and P53 Gene Expressions in Multivariable Analysis of Breast Cancer Prognosis

Overexpression of P53 is prognostic for aromatase inhibitor resistance in early stage postmenopausal patients with ER-positive breast cancer

Novel Prognostic Markers for Patients with Triple-Negative Breast Cancer

[Clinical-pathological characteristics and survival of triple negative breast cancer].

Clinical features and prognosis of triple-negative breast cancer